INTRODUCTION
============

The population worldwide is aging. With increased life expectancy for older adults, the incidence of osteoporotic fractures has also increased.[@B1][@B2][@B3][@B4][@B5] To prevent osteoporotic fractures, every nation around the globe is dedicated to treating osteoporosis,[@B6][@B7][@B8][@B9][@B10][@B11] and initiatives are growing to minimize the incidence of osteoporotic fractures.[@B12] These fractures in older adults can lead to elevated mortality and morbidity that can decrease the quality of life,[@B6][@B7][@B8] and osteoporotic fracture patients are also at danger of secondary osteoporotic fractures.[@B13]

According to several studies, the first osteoporotic fracture increases the risk of later fractures.[@B14][@B15][@B16] A meta-analysis revealed that a history of fracture considerably increases the danger of any fracture, compared to the lack of a previous fracture (RR: 1.86; 95% CI: 1.75--1.98).[@B17] Furthermore, a second hip fracture increases the risk of mortality, extra comorbidities, and reduced independence.[@B18] Cheung, et al.[@B19] reported the most updated incidence rate and projected population size of hip fractures for nine members of the Asian Federation of Osteoporosis Societies. They predicted that the number of hip fractures would increase from 1124060 in 2018 to 2563488 in 2050, an increase of 2.28-fold. This increase is mainly due to changes in demographics of the population, particularly in China and India, which have the largest population sizes. The direct costs of hip fracture is expected to rise from USD 9.5 billion in 2018 to USD 15 billion in 2050 (a 1.59-fold increase). To keep the total number of hip fractures constant over time, a 2--3% decrease in the incidence rate of hip fracture is required annually. They concluded that, despite the availability of better diagnosis, treatment, and prevention for fracture over recent years, hip fracture remains a key public health issue in Asia and that healthcare policy should aim to reducethe burden of hip fracture in Asia.[@B19] However, studies on the incidence and mortality of refractures following an initial osteoporotic fracture are restricted owing to their comparatively rare incidences and the need for a large sample size.

Therefore, the objectives of this research were: 1) to determine the incidence of osteoporotic refractures and fracture locations and 2) to assess related mortality rates over a median follow up of 3 years using a nationwide claims database.

MATERIALS AND METHODS
=====================

Data source
-----------

This research used information from the 2002 to 2013 claims database of the Korean National Health Insurance (KNHI). The KNHI gathers cohort information representing the population of the country. The sample cohort covers 1025340 subjects (2.2% of the total population of 47851928) through random stratification according to sex, age, and income level. The database provides reimbursement data for each medical service, including fundamental demographics of the patients, clinic or hospital identifiers, disease code, expenses incurred, health screening outcomes, individual and family health history, health behaviors, and death-related data.[@B20] This study was approved by the Institutional Review Board (IRB) of Chung-Ang University Hospital \[IRB No. C2014086(1282)\]. The requirement for informed consent was waived as this study was based on review of data that were regularly gathered.

Subjects
--------

Selection criteria were: 1) those aged 50 years or older who were diagnosed with osteoporotic fractures, including the hip, spine, humerus, and distal radius, in the national database from 2007 to 2012; 2) those who were followed up until 2013 with original fractures reported from 2007 to 2012; and 3) those who were followed up for at least 1 year ([Fig. 1](#F1){ref-type="fig"}). Patients with a history of fracture from 2002 to 2006 were excluded from this research. With the exception of cosmetic surgery and traffic accident-related injuries, the KNHI program includes 100% of the population. All clinics and hospitals send patient information including diagnosis \[as described in the International Classification of Diseases, 10th Revision (ICD-10)\] and NHIS claims medical expenses. The NHIS database allows for research of non-traumatic osteoporotic fractures as it does not include high-energy injuries, such as traffic accidents or industrial accidents. All information related to patients and diseases can be found from NHIS data. This information has been used in several epidemiological studies in Korea based on diagnostic codes including ICD-10 code and operational definitions for hip, spine, distal radius, and humerus fractures.[@B21][@B22][@B23][@B24]

Definition of osteoporotic fracture
-----------------------------------

KNHI data of outpatient visits or hospital admissions of patients aged 50 years and older from January 1, 2002 to December 31, 2012 were analyzed. Fractures related to osteoporosis were recognized for seven processes (open reduction of fractured extremity-femur, closed pinning-femur, closed pelvis/femur fixation, closed reduction of fractured extremity-pelvis/femur, bone traction, skin traction, and hemiarthroplasty-hip) and the ICD-10 codes S72.0 (femoral neck fracture), S72.1 (pertrochanteric fracture), S22.0 (traumatic spine fracture), S22.1 (traumatic spine fracture), S32.0 (traumatic spine fracture), M48.4 (traumatic vertebra fracture), M48.5 (traumatic vertebra fracture), S52.5 (traumatic distal fracture), S52.6 (traumatic distal radius/ulna fracture), S42.2 (proximal humerus fracture), and S42.3 (humerus shaft fracture), as well as fractures in general.[@B4][@B21][@B25]

Definition of refracture and survival duration
----------------------------------------------

Refracture was classified as a fracture of bone in one of four initial components (hip, humerus, spine, and wrist) that occurred after 6 months (180 days) based on the last claim date.[@B26] The re-fracture was defined after a 6-month untreated period using the same operational definition as described previously.[@B27][@B28] Survival duration was defined as the length from the first fracture date to the date of death between 2007 and 2012.

Mortality after osteoporotic fractures in patients
--------------------------------------------------

NHIS data were combined with National Statistical Office domestic mortality data to determine survival for each patient during the follow-up period after osteoporotic fracture. From the index date of the first refracture event, the mortality rate of patients with refracture was calculated.

Adjustment of comorbidity index and disability
----------------------------------------------

Medical comorbidity was based on the modified Charlson\'s Comorbidity Index, which was calculated as the amount of points given for disease circumstances conditions as follows: one point for myocardial infarction, deep vein thrombosis, congestive heart failure, peripheral vascular disease, dementia, arthritis, chronic obstructive pulmonary disease, diabetes mellitus, or ulcer; two points for stroke or cancer; and three points for liver cirrhosis. Thus, possible total scores ranged from 0 to 15, with higher scores indicating poorer health status.[@B29]

In terms of disability, its class (physical disability or all-cause disability) and severity (grade 1: ordinary, grade 1--2: serious, grade 3--6: mild) were obtained from the NHIS database. Disability was assessed by the accountable physician according to particular guidelines developed by the Korean government.

Statistical analyses
--------------------

To evaluate the relationship between recurrence of osteoporotic fracture and death, the time from incidence to death was calculated, and recurrence from incidence of the final episode to death was calculated. A life table was used to calculate the cumulative incidence of refracture. Cumulative incidence was described as the likelihood of a specific case occurring, such as the occurrence of a specific disease. It was calculated as the amount of topics at the start of the research, separating the amount of new refractures over a period of time. The risk of mortality was calculated using Cox proportional hazards regression. A life table was also used to calculate the rate of survival. All data analyses were performed using SAS statistical package version 9.4 (SAS Institute, Cary, NC, USA).

RESULTS
=======

A total of 18956 first-time instances of osteoporotic fracture were reported between 2007 and 2012, with a median follow-up of 3.1 years (range, 1 to 7 years). Demographic features of each fracture site and the refracture states of patients are summarized in [Table 1](#T1){ref-type="table"}.

There were 4641 (24.50%) male patients and 14315 (75.50%) female patients. A total of 724 (3.80%) patients showed serious impairment related with the severity of the disease, and 2999 (15.80%) patients died during the follow-up period. Of 18956 patients, 2941 (15.50%) had at least one refracture. There were statistically significant differences in sex, age, and mortality between the refracture group and the non-refracture group ([Table 1](#T1){ref-type="table"}, [Fig. 1](#F1){ref-type="fig"}). Osteoporotic fracture in the spine had the highest number of cases (n=8600, 45.40%), followed by wrist fracture (n=6243, 32.90%), fracture in the humerus (n=829, 4.40%), and hip fracture (n=3284, 17.30%). Of 2941 patients with refractures, 1116 (37.95%), 815 (27.71%), 677 (23.02%), and 333 (11.32%) events were associated with the spine, hip, wrist, and humerus, respectively. The incidences of re-fracture according to the first fracture site were 12.83% (1103/8600) in spine and 22.50% (739/3284) in hip. The incidence of wrist refracture in a previous wrist fracture was 6.63% (414/6243), and the frequency of humeral re-fracture involving a previous humeral fracture was 35.83% (297/829) ([Table 2](#T2){ref-type="table"}).

Mortality in the re-fracture group (63.5/1000 person-years) was higher than that in the non-refracture group (44.5/1000 person-years) during the study period ([Table 3](#T3){ref-type="table"}). After adjusting for age, sex, income, and comorbidity index, the mortality rate in patients with re-fracture was 1.4 times \[hazard ratio (HR): 1.4, 95% confidence interval (CI): 1.26--1.55, *p*\<0.001\] higher than that in patients without re-fracture over a median follow-up of 3 years ([Fig. 2](#F2){ref-type="fig"}).

According to the site of first fracture, mortality risk was decreased in the order of hip (HR: 1.68, *p*\<0.001), humerus (HR: 1.41, *p*\<0.001), spine (reference), and wrist (HR: 0.52, *p*\<0.001). In addition, the mortality risks according to the site of first refracture (reference=non-refracture) were decreased in the order of hip (HR=1.52, *p*\<0.001), spine (HR=1.09, *p*=0.329), humerus (HR=0.93, *p*=0.722), and wrist (HR=0.69, *p*=0.072) ([Table 4](#T4){ref-type="table"}).

Adults \>85 years of age showed greater danger of re-fracture than those aged between 50 and 54 years (HR: 1.43, 95% CI: 1.17--1.76, *p*\<0.001). The risk of re-fracture was higher in female (HR: 1.37, 95% CI: 1.30--1.44, *p*\<0.001) than in male.

DISCUSSION
==========

Although attempts have been made to prevent secondary fractures in patients with osteoporotic fracture over the past several centuries, information about the incidence, morbidity, mortality, and financial burden associated with secondary fractures is still limited for patients with osteoporotic fractures. Thus, this study determined the incidence and mortality of osteoporotic refractures based on information from domestic claims for health insurance. During the study period with a median follow-up of 3 years (range, 1 to 7 years), the incidence of refractures among complete osteoporotic fractures was 15.5% (2941/18956 patients). Incidences rates of refractures in the spine, hip, wrist, and humerus were 37.95%, 27.71%, 23.02%, and 11.32%, respectively. Cumulative mortality rates for nonrefracture and re-fracture groups at 1 year of follow up were 7.2% and 9.1%, respectively. During the study period, cumulative mortality was higher in the re-fracture group than that in the non-refracture group. After adjusting for age, sex, income, and comorbidity, the mortality rate was 1.2 times greater in patients with re-fracture than that in patients without re-fracture (Model 2, HR: 1.20, 95% CI: 1.08--1.34, *p*\<0.001). Risk ratios for hip, humerus, and wrist refractures were 1.68, 1.41, and 0.52, respectively. Adults \>85 years of age had a greater risk of refracture than those aged between 50 and 54 years (HR: 1.43, 95% CI: 1.17--1.76, *p*\<0.001), and the risk of refracture was greater in females (HR: 1.37, 95% CI: 1.30--1.44, *p*\<0.001) than in males.

Hsiao, et al.[@B30] determined the incidence of osteoporotic fracture in patients over 65 years of age using the National Health Insurance Database. They indicated that within the first year of original fracture, 45% experienced complete refractures. Although the overall incidence of secondary fracture depended on follow-up periods, 50% of cases showed refractures within 3 years after the primary fracture.[@B27][@B31][@B32] In the present study, the incidence of re-fracture during follow up corresponded with the results of other studies. The incidence of refracture improved significantly up to 2 years in this research, and it decreased gradually to a plateau. Of all refractures, 21% and 55% occurred at 1 and 2 years, respectively. Considering such trends in patients with primary osteoporotic fractures, early prevention appears mandatory to minimize the incidence of refracture.

Nakayama, et al.[@B33] performed a historical cohort study of all patients aged at least 50 years who had a 6-month history of minimal trauma fracture and presented to the emergency departments of a tertiary hospital with and without a fracture liaison service. They reported a 30% reduction in the rate of refracture at the fracture liaison service hospital and a 40% reduction in major refractures (hip, spine, femur, pelvis, or humerus).

Klotzbuecher, et al.[@B34] performed a meta-analysis and revealed that past history of wrist fracture not only increases the risk of subsequent wrist fracture \[odds ratio (OR): 3.3\], but also increases the risk of hip fracture (OR: 1.9). Similarly, past history of hip fracture increased the risk of subsequent hip fracture (OR: 2.3) in peri- or post-menopausal females. A common fracture, irrespective of its location, reduced the danger of subsequent fracture, including pooled vertebral and non-vertebral fractures (OR: 2).[@B34]

van Staa, et al.[@B35] used British cohort information to evaluate the incidence of subsequent fractures. They found that a previous tibia, fibula, ankle, femur, hip, radius, ulna, rib, or humerus fracture increased the risk of subsequent fracture, with corresponding ORs ranging from 2 to 3. Specifically, patients with a history of radius or ulna fracture had the highest risk of humerus fracture (OR: 5.8, 95% CI: 5.5--6.1).[@B35]

Overall, patients with osteoporotic fracture reported greater hip, spine, proximal humerus, and distal radius mortality. These results often matched secondary fractures in main fractures. Bliuc, et al.[@B36] performed a long-term follow-up cohort study to investigate the mortality of osteoporotic fractures in patients above 60 years of age. They reported 2.99-fold and 1.91-fold increases in mortality in male and female patients with refractures, respectively. Refracture within 5 years of an initial fracture significantly increased the mortality. Furthermore, mortality was moderately increased within 10 years. In the present study, the mortality rate in patients with refracture was 1.2 times higher than that in the non-refracture group (HR: 1.20, 95% CI: 1.08--1.34, *p*\<0.001) after adjusting for age, sex, income, and comorbidity index. During a follow-up duration of 4 years, risks of mortality rate (HR: 1.27 at 1 year, 1.25 at 2 years, 1.29 at 3 years, 1.10 at 4 years, and 0.99 at 5 years) were higher in the re-fracture group than those in the non-refracture group.

Hsiao, et al.[@B30] found that important risk factors are hip (HR=1.45), spine (HR=1.59), female sex (HR=1.41), and age over 85 years (HR=1.26). Our findings also showed that advanced age and female sex were risk factors for refracture. However, the frequency of refracture in this study was the highest at the humerus and hip joints depending on the primary fracture site. The incidence of humerus-related refracture was 3.7 times greater than in the hip and 2 times greater than in the spine.

This study has several limitations. First, bone mineral density data or laboratory data, such as vitamin D, calcium, body mass index, smoking/alcohol status, or caffeine use, were not considered because this study was based on the National Claims Registry database. Second, although the operative definition of this study excluded pathologic fractures, it was impossible to clinically diagnose any disease associated fractures. Therefore, fracture incidence might have been overestimated. Third, mortality due to a specific medical condition or non-medical usage was not analyzed. Additional research studies investigating refracture and mortality based on large-scale registry data are needed. Fourth, trends in refracture could be compared to other studies. The secular trend of re-fracture in this study cannot be generalized due to the study period and the characteristics of the database. Finally, cox-regression analysis was used to analyze the effect of refracture on mortality. However, competing risk analysis was not performed. In addition, statistical processing was difficult due to the use of claim data. Nevertheless, cohort data from the NHIS were used to analyze refracture patterns for a nationally representative population. Reporting the incidence according to different scenarios of major osteoporotic refractures would be meaningful.

In summary, in this nationwide study, the incidence of osteoporotic re-fracture was 15.5%. The mortality rate in refracture patients was found to be 1.2 times higher than that in non-refracture patients over a median follow-up of 3 years.
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###### Demographic Characteristics in Terms of Osteoporotic Fracture Pattern

![](ymj-60-969-i001)

  Variables                            Total   Recurrence   *p* value   First fracture location   *p* value                                                                       
  ------------------------------------ ------- ------------ ----------- ------------------------- ----------- --------- ------ ------- ----- ------ ------ ------- ------ ------- ---------
  Total                                18956   16015        84.50       2941                      15.50                 8600   45.40   829   4.40   6243   32.90   3284   17.30   
  Sex                                                                                                         \<0.001                                                             0.046
   Male                                4641    4105         88.45       536                       11.55                 2262   48.74   222   4.78   1044   22.50   1113   23.98   
   Female                              14315   11910        83.20       2405                      16.80                 6338   44.28   607   4.24   5199   36.32   2171   15.16   
  Age (yr)                                                                                                    \<0.001                                                             \<0.001
   50--54                              1770    1617         91.36       153                       8.64                  534    30.17   111   6.27   946    53.45   179    10.11   
   55--59                              2109    1932         91.61       177                       8.39                  634    30.06   110   5.22   1176   55.76   189    8.96    
   60--64                              2192    1935         88.28       257                       11.72                 819    37.36   107   4.88   1040   47.45   226    10.31   
   65--69                              2914    2436         83.60       478                       16.40                 1362   46.75   133   4.56   1052   36.10   367    12.59   
   70--74                              3336    2678         80.28       658                       19.72                 1754   52.58   132   3.96   916    27.46   534    16.00   
   75--79                              2976    2417         81.22       559                       18.78                 1670   56.12   115   3.86   572    19.22   619    20.80   
   80--84                              2025    1619         79.95       406                       20.05                 1064   52.54   67    3.31   328    16.20   566    27.95   
   ≥85                                 1634    1381         84.52       253                       15.48                 763    46.70   54    3.30   213    13.04   604    36.96   
  Income quintile                                                                                             0.322                                                               \<0.001
   0                                   1073    920          85.74       153                       14.26                 548    51.07   55    5.13   212    19.76   258    24.04   
   1                                   2867    2433         84.86       434                       15.14                 1281   44.68   117   4.08   991    34.57   478    16.67   
   2                                   2291    1932         84.33       359                       15.67                 1020   44.52   106   4.63   792    34.57   373    16.28   
   3                                   2917    2463         84.44       454                       15.56                 1310   44.91   120   4.11   1034   35.45   453    15.53   
   4                                   3687    3142         85.22       545                       14.78                 1612   43.72   168   4.56   1296   35.15   611    16.57   
   5                                   6121    5125         83.73       996                       16.27                 2829   46.22   263   4.30   1918   31.33   1111   18.15   
  Disability severity classification                                                                          0.037                                                               \<0.001
   Normal                              15628   13239        84.71       2389                      15.29                 7014   44.88   686   4.39   5568   35.63   2360   15.10   
   Mild                                2604    2157         82.83       447                       17.17                 1262   48.46   81    3.11   582    22.35   679    26.08   
   Severe                              724     619          85.50       105                       14.50                 324    44.75   62    8.56   93     12.85   245    33.84   
  Charlson comorbidity score                                                                                  \<0.001                                                             \<0.001
   0                                   8303    7212         86.86       1091                      13.14                 3523   42.43   360   4.34   3309   39.85   1111   13.38   
   1                                   6151    5049         82.08       1102                      17.92                 2915   47.39   256   4.16   1815   29.51   1165   18.94   
   2                                   2474    2058         83.19       416                       16.81                 1150   46.48   116   4.69   693    28.01   515    20.82   
   ≥3                                  2028    1696         83.63       332                       16.37                 1012   49.90   97    4.78   426    21.01   493    24.31   

###### Refracture Rate according to First Osteoporotic Fracture Site
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                               Number of subject   Location of re-fracture                                                           
  ---------------------------- ------------------- ------------------------- ------- ------ ------- ----- ------- ----- ------ ----- -------
  Total                        18956               2941                      15.50   1424   7.51    297   1.57    467   2.46   753   3.97
  Location of first fracture                                                                                                         
   Spine                       8600                1116                      12.98   1103   12.83   0     0.00    5     0.06   8     0.09
   Humerus                     829                 333                       40.17   4      0.48    297   35.83   30    3.62   2     0.24
   Wrist                       6243                677                       10.84   259    4.15    0     0.00    414   6.63   4     0.06
   Hip                         3284                815                       24.82   58     1.77    0     0.00    18    0.55   739   22.50

###### Mortality Rates during Follow Up (2007 to 2012)
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  Year      Non-refracture^\*^   Refracture^\*^
  --------- -------------------- ----------------
  2007      44.0                 74.1
  2008      46.6                 65.8
  2009      41.7                 52.6
  2010      42.7                 69.9
  2011      45.9                 60.9
  2012      47.0                 66.3
  Average   44.5                 63.5

^\*^1000 person-years.

###### Mortality Risk for Each Refracture Site in Refracture Patients, Compared to Non-Refracture Patients

![](ymj-60-969-i004)

  Fracture location   Original fracture   Refracture (reference: non-refracture)                                 
  ------------------- ------------------- ---------------------------------------- --------- ------ ------------ ---------
  Spine               Reference                                                              1.09   0.92--1.28   0.329
  Humerus             1.41                1.18--1.69                               \<0.001   0.93   0.61--1.41   0.722
  Wrist               0.52                0.46--0.58                               \<0.001   0.69   0.45--1.03   0.072
  Hip                 1.68                1.55--1.82                               \<0.001   1.52   1.31--1.76   \<0.001

CI, confidence interval.

Adjusted for age, sex, income, and Charlson Comorbidity Index.
